Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The gradual deterioration of cognitive functions in Alzheimer's disease is paralleled by a hierarchical progression of amyloid-beta and tau brain pathology. Recent findings indicate that toxic oligomers of amyloid-beta may cause propagation of pathology in a prion-like manner, although the underlying mechanisms are incompletely understood. Here we show that small extracellular vesicles, exosomes, from Alzheimer patients' brains contain increased levels of amyloid-beta oligomers and can act as vehicles for the neuron-to-neuron transfer of such toxic species in recipient neurons in culture. Moreover, blocking the formation, secretion or uptake of exosomes was found to reduce both the spread of oligomers and the related toxicity. Taken together, our results imply that exosomes are centrally involved in Alzheimer's disease and that they could serve as targets for development of new diagnostic and therapeutic principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, in damaged environments, like AD, exosomes are involved in the transportation of damaging proteins like Aβ and Tau [116].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“A previous study has shown that sEVs isolated from the brains of AD patients contain elevated levels of Aβ oligomers [141].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“These EVs have been discovered as possible transporters for transferring toxic protein species from neuron to neuron, as has been shown in vitro.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [141]
The cited source says what the claim attributes to it.
In the citing paper
“oAβ42 has been detected within neuronal exosomes.”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Data from cells treated with these exosomes also revealed that the exosomes facilitated delivery of oAβ42 and induced toxic effects [24].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200 · cited 1×
“These findings suggest that exosomes might be the main mediator of the pathogenic progression in AD as was recently suggested for dementia with Lewy bodies [41].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346 · cited 2×
“It has been suggested that exosomal release may provide an alternative disposal mechanism to lysosomal degradation of oAβ [5] or other proteins that are resistant to degradation [55].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The nature of the propagating species has not been established, although several studies have indicated a particularly pathogenic role of soluble oAβ on synaptic and cellular functions and structure [13, 32, 50, 60].”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“1 3 Aß, tau and α-synuclein [12, 17, 46, 59] and can propagate tau pathology [4].”
BackgroundAlzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343 · cited 2×
“Accordingly, exosomes from blood [22], CSF [17, 49] and cell cultures [46] have been shown to contain monomeric Aβ and tau, but so far, no study has addressed the presence of oAβ in exosomes from human AD brains.”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · cited 1×
“Here dystrophic neurites with neurite beading and loss of neurite branching were identified, known early signs of neurodegeneration [51].”
Background
Research works printed but not linked: 1
- Tucker S, Möller C, Tegerstedt K, Lord A, Laudon H, Sjödahl J, Söderberg L, Spens E, Sahlin C, Waara ER et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. JAD 43:575–588. https://doi.org/10.3233/JAD-140741 · DOI · Paper page
Cited by
Extracellular Vesicles and Neurodegenerative Diseases
Hill, A. F. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0147-18.2019 · Cited by 437
“These A -containing vesicles were also shown to be neurotoxic to primary cultured neurons indicating, at least in vitro, functional activity associated with the vesicle harboring this pathogenic protein (Sardar Sinha et al., 2018).”
BackgroundThe emerging role of exosomes in mental disorders
Saeedi, S., Israel, S., Nagy, C., & Turecki, G. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0459-9 · Cited by 370
Exosomes: roles and therapeutic potential in osteoarthritis
Ni, Z., Zhou, S., Li, S., Kuang, L., Chen, H., Luo, X., Ouyang, J., He, M., Du, X., & Chen, L. (2020) · Bone Research · doi:10.1038/s41413-020-0100-9 · Cited by 288
Challenges and hopes for Alzheimer’s disease
Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291
Pulliam, L., Sun, B., Mustapic, M., Chawla, S., & Kapogiannis, D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0695-4 · Cited by 248
CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges
Hornung, S., Dutta, S., & Bitan, G. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00038 · Cited by 238
Li, Y., Zhang, J., Wan, J., Liu, A., & Sun, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110887 · Cited by 197
Exosomal targeting and its potential clinical application
He, J., Ren, W., Wang, W., Han, W., Jiang, L., Zhang, D., & Guo, M. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01087-1 · Cited by 199
Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease
Delpech, J.-C., Herron, S., Botros, M. B., & Ikezu, T. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.02.007 · Cited by 193
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 182
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease
Soares Martins, T., Trindade, D., Vaz, M., Campelo, I., Almeida, M., Trigo, G., da Cruz e Silva, O. A. B., & Henriques, A. G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15112 · Cited by 174
Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
Mosquera-Heredia, M. I., Morales, L. C., Vidal, O. M., Barceló, E., Silvera-Redondo, C., Vélez, J. I., & Garavito-Galofre, P. (2021) · Biomedicines · doi:10.3390/biomedicines9081061 · Cited by 163
Exosomes in Inflammation and Inflammatory Disease
Chan, B. D., Wong, W., Lee, M. M., Cho, W. C., Yee, B. K., Kwan, Y. W., & Tai, W. C. (2019) · PROTEOMICS · doi:10.1002/pmic.201800149 · Cited by 166
You, Y., Muraoka, S., Jedrychowski, M. P., Hu, J., McQuade, A. K., Young‐Pearse, T., Aslebagh, R., Shaffer, S. A., Gygi, S. P., Blurton‐Jones, M., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12183 · Cited by 161
“For instance, AD brain-derived EVs have been shown to contain pathogenic proteins, such as A β , hyper-phosphorylated tau, and α -synuclein (Muraoka, Deleo, et al., 2020; Sardar Sinha et al., 2018).”
Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease
Webster, J. M., Darling, A. L., Uversky, V. N., & Blair, L. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01047 · Cited by 160
“…Batulan et al., 2016; Fontaine et al., 2016; Guix et al., 2018; Katsinelos et al., 2018; Lee et al., 2018; Pérez et al., 2018; Reddy et al., 2018; Sardar Sinha et al., 2018); other mechanisms, including direct transport and tunneling nanotubes, may also contribute (Abounit et al., 2016; Batulan…”
Muraoka, S., Jedrychowski, M. P., Yanamandra, K., Ikezu, S., Gygi, S. P., & Ikezu, T. (2020) · Cells · doi:10.3390/cells9091959 · Cited by 160
Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
Wei, H., Xu, Y., Chen, Q., Chen, H., Zhu, X., & Li, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2490-4 · Cited by 168
Yates, A. G., Pink, R. C., Erdbrügger, U., Siljander, P. R., Dellar, E. R., Pantazi, P., Akbar, N., Cooke, W. R., Vatish, M., Dias‐Neto, E., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12190 · Cited by 147
Huo, L., Du, X., Li, X., Liu, S., & Xu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.738442 · Cited by 145
“Sardar Sinha et al., 2018 Rat embryos cortical neurons and neuroblastoma N2a cells – Tau protein Mediating the trans-synaptic transmission of tau protein.”
BackgroundInsulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Berlanga-Acosta, J., Guillén-Nieto, G., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., García-Ojalvo, A., Valdés-Sosa, M. J., & Valdés-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 136
“Interestingly, Aβ oligomers that accumulate inside cells can subsequently spread its pathologic message to normal healthy neurons via exosomes, promoting a variety of neurodegenerative changes (148).”
BackgroundThe emerging role of exosomes in Alzheimer’s disease
Zhang, T., Ma, S., Lv, J., Wang, X., Afewerky, H. K., Li, H., & Lu, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101321 · Cited by 139
Molecular Communication of a Dying Neuron in Stroke
Puig, B., Brenna, S., & Magnus, T. U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092834 · Cited by 156
Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?
Mihevc, S. P., & Majdič, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00604 · Cited by 163
“…in a prion-like mechanism might also exploit exosomes, which can seed Aβ not only as vehicles for the neuron-to-neuron transfer (Zheng et al., 2017; Sardar Sinha et al., 2018) but also between distant brain regions (i.e., from the dentate gyrus to other regions of hippocampus and to the cortex)…”
BackgroundXiao, Y., Zheng, L., Zou, X., Wang, J., Zhong, J., & Zhong, T. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1625677 · Cited by 144
“[52] showed that Alzheimer brain EVs were enriched with”
BackgroundA Budding Relationship: Bacterial Extracellular Vesicles in the Microbiota-Gut-Brain Axis
Haas‐Neill, S., & Forsythe, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238899 · Cited by 142
“These EV can spread toxic Aβ oligomers and cause toxicity in neurons [143].”
BackgroundEmerging roles of extracellular vesicles in neurodegenerative disorders
You, Y., & Ikezu, T. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104512 · Cited by 136
“Moreover, AD patients’ brains derived exosomes contain elevated toxic Aβ oligomers that can promote the neuron-to-neuron transfer of oligomers which cause toxicity in culture [133].”
BackgroundExosomes of pasteurized milk: potential pathogens of Western diseases
Melnik, B. C., & Schmitz, G. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1760-8 · Cited by 136
Roles of Exosomes in Ocular Diseases
Liu, J., Jiang, F., Jiang, Y., Wang, Y., Li, Z., Shi, X., Zhu, Y., Wang, H., & Zhang, Z. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s277190 · Cited by 139
“Toxic amyloid-beta oligomers can be carried by exosomes from the brain of people with Alzheimer’s disease, allowing these oligomers to move between neurons and worsen the disease.(130) Zhang et al(14) have shown that exosomes in serum produced after hepatic ischemia-reperfusion may cause oxidative stress and damage hi…”
BackgroundExosomes From Astrocyte Processes: Signaling to Neurons
Venturini, A., Passalacqua, M., Pelassa, S., Pastorino, F., Tedesco, M., Cortese, K., Gagliani, M. C., Leo, G., Maura, G., Guidolin, D., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01452 · Cited by 127
Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review
Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126
Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
Lee, S., Mankhong, S., & Kang, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071728 · Cited by 124
Is Alzheimer’s Disease a Liver Disease of the Brain?
Bassendine, M. F., Taylor-Robinson, S. D., Fertleman, M., Khan, M., & Neely, D. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-190848 · Cited by 124
“They can carry cargo across the BBB [17] and are carriers of A in AD [18].”
BackgroundCohn, W., Melnik, M., Huang, C., Teter, B., Chandra, S., Zhu, C., McIntire, L. B., John, V., Gylys, K. H., & Bilousova, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.766082 · Cited by 122
Neuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 141
“Moreover,currenthypotheseshaveshownthreeA β propagationways: direct cell contact 91 , exosomes 92 – 94 , and tunnelling nanotubes between cells 95 – 97 .”
BackgroundPropagation of Tau via Extracellular Vesicles
Pérez, M., Avila, J., & Hernández, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00698 · Cited by 118
Identification of altered exosomal microRNAs and mRNAs in Alzheimer's disease
Su, L., Li, R., Zhang, Z., Liu, J., Du, J., & Wei, H. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101497 · Cited by 118
Amyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
“A recent work highlighted the importance of exosomes, small extracellular vesicles, in AβOs neuron-to-neuron transfer (Sardar Sinha et al., 2018).”
Sanders, O., & Rajagopal, L. (2020) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-200191 · Cited by 113
Zou, Z., Han, L., Xu, G., Hu, Y., Zhang, W., & Tian, K. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417422 · Cited by 126
Understanding extracellular vesicle and nanoparticle heterogeneity: Novel methods and considerations
Phillips, W., Willms, E., & Hill, A. F. (2021) · PROTEOMICS · doi:10.1002/pmic.202000118 · Cited by 125
Sanadgol, N., Abedi, M., Hashemzaei, M., Kamran, Z., Khalseh, R., Beyer, C., & Voelz, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03528-2 · Cited by 123
Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease
Gabrielli, M., Prada, I., Joshi, P., Falcicchia, C., D’Arrigo, G., Rutigliano, G., Battocchio, E., Zenatelli, R., Tozzi, F., Radeghieri, A., et al. (2022) · Brain · doi:10.1093/brain/awac083 · Cited by 106
“cultured neurons and intracellularly transferred between neurons through axonal projections, spreading neurotoxicity.(80,81) Our study goes well beyond these works by showing that: (i) large Aβ-EVs, Figure 6 CHO-EVs propagate LTP impairment in the EC–DG circuit.”
Microglial Exosomes in Neurodegenerative Disease
Guo, M. A., Hao, Y., Feng, Y., Li, H., Mao, Y., Dong, Q., & Cui, M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.630808 · Cited by 117
Neuronal extracellular vesicles and associated microRNAs induce circuit connectivity downstream BDNF
Antoniou, A., Auderset, L., Kaurani, L., Sebastian, E., Zeng, Y., Allahham, M., Cases-Cunillera, S., Schoch, S., Gründemann, J., Fischer, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112063 · Cited by 107
Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
Rizvanov, A. A., Shaimardanova, A. A., Solovyeva, V. V., Chulpanova, D. S., James, V. H., & Kitaeva, K. V. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266908 · Cited by 110
“In case of CNS diseases, such as neurodegenerative, neuroinflammatory diseases and brain tumors, exosomes and MVs, on the one hand, can remove toxic proteins and aggregates from the affected cells, and on the other, distribute pathogenic agents to healthy cells (Rufino-Ramos et al., 2017; Sardar Sinha et al., 2018).”
BackgroundBrain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yu, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 104
Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents
Takahashi, Y., & Takakura, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108352 · Cited by 94
Yin, T., Liu, Y., Ji, W., Zhuang, J., Chen, X., Gong, B., Chu, J., Liang, W., Gao, J., & Yin, Y. (2023) · Theranostics · doi:10.7150/thno.81860 · Cited by 98
“Exosomes are nanosized EVs with diameters of 40–160 nm that are released by a wide range of cell lines, including those found in the brain, contributing to cell-cell communication [16-19].”
BackgroundExtracellular vesicles as personalized medicine
Beetler, D. J., Di Florio, D. N., Bruno, K. A., Ikezu, T., March, K. L., Cooper, L. T., Wolfram, J., & Fairweather, D. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101155 · Cited by 101
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
Leggio, L., Paternò, G., Vivarelli, S., L’Episcopo, F., Tirolo, C., Raciti, G., Pappalardo, F., Giachino, C., Caniglia, S., Serapide, M. F., et al. (2020) · Biomolecules · doi:10.3390/biom10091327 · Cited by 100
“In NDs, EVs were initially characterized as vehicles for misfolded or dysfunctional mutant proteins, such as amyloid-beta oligomers in Alzheimer’s disease (AD) [47], SOD1 in amyotrophic lateral sclerosis (ALS) [48], or α-Syn in PD [49].”
BackgroundAlpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
Tang, Q., Gao, P., Arzberger, T., Höllerhage, M., Herms, J., Höglinger, G., & Koeglsperger, T. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04138-0 · Cited by 103
ER stress activates immunosuppressive network: implications for aging and Alzheimer’s disease
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01904-z · Cited by 96
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xia, X., Wang, Y., & Zheng, J. C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00330-0 · Cited by 92
Estes, R., Lin, B. C., Khera, A., & Davis, M. Y. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.788695 · Cited by 109
Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles
Zhuo, Z., Wang, J., Luo, Y., Zeng, R., Zhang, C., Zhou, W., Guo, K., Wu, H., Sha, W., & Chen, H. H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.027 · Cited by 98
Liu, C., Yazdani, N., Moran, C. S., Salomon, C., Seneviratne, C. J., Ivanovski, S., & Han, P. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.04.022 · Cited by 101
The role of NOX inhibitors in neurodegenerative diseases
Barua, S., Kim, J. Y., Yenari, M. A., & Lee, J. E. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.07.1721 · Cited by 97
Lee, J. H., Kim, H., Heo, Y., Yoo, Y. K., Han, S. I., Kim, C., Hur, D., Kim, H., Kang, J. Y., & Lee, J. H. (2019) · The Analyst · doi:10.1039/c9an01140d · Cited by 91
Anđjus, P. R., Kosanović, M., Milicevic, K. D., Gautam, M., Vainio, S. J., Jagečić, D., Kozlova, E. N., Pivoriūnas, A., Chachques, J. C., Sakaj, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186859 · Cited by 97
Amyloid-β and Tau in Alzheimer’s disease: pathogenesis, mechanisms, and interplay
Abdulkhaliq, A. A., Kim, B., Almoghrabi, Y. M., Khan, J., Ajoolabady, A., Ren, J., Bahijri, S., Tuomilehto, J., Borai, A., & Pratico, D. (2026) · Cell Death & Disease · doi:10.1038/s41419-025-08186-8 · Cited by 87
Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
Badhwar, A., & Haqqani, A. S. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12001 · Cited by 87
Flores‐Bellver, M., Mighty, J., Aparicio‐Domingo, S., Li, K. V., Shi, C., Zhou, J., Cobb, H., McGrath, P. S., Michelis, G., Lenhart, P., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12165 · Cited by 96
“In addition, when Aβ concentration overwhelms the lysosomal degradation compartment leads to Aβ aggregation (Hu et al., 2009; Li et al., 2012) and propagation of toxic Aβ aggregates via EVs (Riva et al., 2019; Sardar Sinha et al., 2018).”
BackgroundSphingolipids in Alzheimer's disease, how can we target them?
Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N., den Hoedt, S., Losen, M., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 87
Crivelli, S. M., Giovagnoni, C., Zhu, Z., Tripathi, P., Elsherbini, A. M., Quadri, Z., Pu, J. Y., Zhang, L., Ferko, B., Berkeš, D., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12233 · Cited by 90
“For instance, in AD, the release of amyloid-β (Aβ) peptides by EVs may be involved in the slow progression of the disease, similarly to prion proteins that mediate their intercellular transfer via EVs (Sardar Sinha et al., 2018).”
BackgroundExtracellular vesicles in neuroinflammation: Pathogenesis, diagnosis, and therapy
Ruan, J., Miao, X., Schlüter, D., Li, L., & Wang, X. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.020 · Cited by 94
Yang, Z., Atiyas, Y., Shen, H., Siedlik, M. J., Wu, J., Beard, K., Fonar, G., Dollé, J.-P., Smith, D. H., Eberwine, J. H., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00274 · Cited by 90
Different sourced extracellular vesicles and their potential applications in clinical treatments
Bahmani, L., & Ullah, M. (2022) · Cells · doi:10.3390/cells11131989 · Cited by 83
Neuropathological assessment of the Alzheimer spectrum
Jellinger, K. A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02232-9 · Cited by 89
Soliman, H. M., Ghonaim, G. A., Gharib, S. M., Chopra, H., Farag, A. K., Hassanin, M. H., Nagah, A., Emad-Eldin, M., Hashem, N. E., Yahya, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910794 · Cited by 81
“2018, provided supportive evidence by showing Aβ oligomer-rich EXOs in Alzheimer’s brains and thus proved that EXOs could act as transfer vesicles among neurons [29].”
BackgroundRiad, A., Lengyel-Zhand, Z., Zeng, C., Weng, C.-C., Lee, V. M.-Y., Trojanowski, J. Q., & Mach, R. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01988-1 · Cited by 81
Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Volpert, O. V., Liu, D., Goetzl, E. J., Mattson, M. P., Greig, N. H., Eitan, E., & Kapogiannis, D. (2021) · Cells · doi:10.3390/cells10050993 · Cited by 81
“Moreover, inhibition of EV secretion in 5xFAD mice results in reduced Aβ plaque burden [51], whereas EVs isolated from the CSF and brains of AD patients carry increased Aβ42 and mediate neurotoxicity in vitro that can be blocked by anti-Aβ antibodies [48,52].”
BackgroundNew advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Ouyang, Q., Meng, Y., Zhou, W., Tong, J., Cheng, Z., & Zhu, Q. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1927055 · Cited by 84
“oAß- Exo Aß oAß- Exo blocks the exosomes’ formation, secretion or uptake In vitro (AF22 cells, SH-SY5Y cells) [179]”
BackgroundTargetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
Yin, Q., Ji, X., Lv, R., Pei, J.-J., Du, Y., Shen, C., & Hou, X. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s240400 · Cited by 77
Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance
Lakpa, K. L., Khan, N., Afghah, Z., Chen, X., & Geiger, J. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09990-7 · Cited by 88
TGF-β Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?
Kandasamy, M., Anusuyadevi, M., Aigner, K. M., Unger, M. S., Kniewallner, K. M., Sousa, D. M. B. D., Altendorfer, B., Mrowetz, H., Bogdahn, U., & Aigner, L. (2020) · Aging and disease · doi:10.14336/ad.2020.0222 · Cited by 77
“Interestingly, intracellular amyloid-β is often found to be co-localized with exosomes [166, 167].”
BackgroundPistono, C., Bister, N., Stanová, I., & Malm, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.623771 · Cited by 75
“…the impact of EVs on the complexity of CNS disorders is not easy, as suggested by the fact that EVs can contribute to the removal of toxic proteins and aggregates, but, on the other hand, they can be involved in the spread of pathogenic proteins (Ngolab et al., 2017; Sardar Sinha et al., 2018).”
BackgroundAcoustofluidic multimodal diagnostic system for Alzheimer's disease
Hao, N., Wang, Z., Liu, P., Becker, R., Yang, S., Yang, K., Pei, Z., Zhang, P., Xia, J., Shen, L., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113730 · Cited by 77
Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling
Hermann, D. M., Peruzzotti-Jametti, L., Giebel, B., & Pluchino, S. (2024) · Brain · doi:10.1093/brain/awad332 · Cited by 77
Reyes, J. F., Sackmann, C., Hoffmann, A., Svenningsson, P., Winkler, J., Ingelsson, M., & Hallbeck, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02007-x · Cited by 73
Self-citationAnalysis and Biomedical Applications of Functional Cargo in Extracellular Vesicles
Qian, F., Huang, Z., Zhong, H., Qi, L., Ai, Y., Xie, Z., Zhang, T., Jiang, B., Zhu, W., Sheng, Y., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c11298 · Cited by 78
Exosomes and autophagy: rekindling the vesicular waste hypothesis
Gudbergsson, J. M., & Johnsen, K. B. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00524-8 · Cited by 76
Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects
Lin, Y., Anderson, J. D., Rahnama, L. M. A., Gu, S. V., & Knowlton, A. A. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00075.2020 · Cited by 81
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Manna, I., De Benedittis, S., Quattrone, A., Maisano, D., Iaccino, E., & Quattrone, A. (2020) · Pharmaceuticals · doi:10.3390/ph13090243 · Cited by 68
“It has been observed that exosomes induce apoptosis, and consequently neuronal loss, by mediating the diffusion between cells of Aβ protein and hyperphosphorylated tau [77].”
BackgroundVassileff, N., Cheng, L., & Hill, A. F. (2020) · Journal of Cell Science · doi:10.1242/jcs.243139 · Cited by 72
Association of Aβ with ceramide-enriched astrosomes mediates Aβ neurotoxicity
Elsherbini, A., Kirov, A. S., Dinkins, M. B., Wang, G., Qin, H., Zhu, Z., Tripathi, P., Crivelli, S. M., & Bieberich, E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00931-8 · Cited by 72
“Recently, extracellular vesicles (EVs), exosomes or microvesicles, were proposed as carrier for transport and uptake of Aβ and tau into neurons [20, 58].”
BackgroundVandendriessche, C., Bruggeman, A., Van Cauwenberghe, C., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 73
“In this context, both Tau and AβO-containing EVs isolated from, respectively, the brain of PS19 Tauopathy mice [63] and AD patients [41] were taken up by neuronal cultures.”
BackgroundInfluentialNeuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
Watson, L. S., Hamlett, E. D., Stone, T. D., & Sims-Robinson, C. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0317-5 · Cited by 74
Gallart-Palau, X., Guo, X., Serra, A., & Sze, S. K. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00623-4 · Cited by 73
Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment
Pathania, A. S., & Challagundla, K. B. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.039 · Cited by 75
Zhao, A., Li, Y., Yan, Y., Qiu, Y., Li, B., Xu, W. L., Wang, Y., Liu, J., & Deng, Y. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00210-5 · Cited by 71
Kumar, R., Tang, Q., Müller, S. A., Gao, P., Mahlstedt, D., Zampagni, S., Tan, Y., Klingl, A., Bötzel, K., Lichtenthaler, S. F., et al. (2020) · Advanced Science · doi:10.1002/advs.201902372 · Cited by 71
Muraoka, S., Lin, W., Chen, M., Hersh, S. W., Emili, A., Xia, W., & Ikezu, T. (2020) · Methods · doi:10.1016/j.ymeth.2020.02.002 · Cited by 71
“These EVs interestingly contribute to the cell-to-cell propagation of the disease [23,25,28,29].”
BackgroundMiyoshi, E., Bilousova, T., Melnik, M., Fakhrutdinov, D., Poon, W. W., Vinters, H. V., Miller, C. A., Corrada, M., Kawas, C., Bohannan, R., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00644-z · Cited by 64
Schiera, G., Di Liegro, C. M., & Di Liegro, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010266 · Cited by 68
Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases
Beatriz, M., Vilaça, R., & Lopes, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635104 · Cited by 64
“Lipids in exosomes share similarities with plasma membrane composition, particularly lipids that are normally found in lipid rafts such as plasma membrane composition cholesterol, sphingomyelin, glycosphingolipids, and ceramide (de Gassart et al., 2003; Llorente et al., 2013; Skotland et al., 2017).”
BackgroundResearch progress on the role of extracellular vesicles in neurodegenerative diseases
Li, Z., Wang, X., Wang, X., Yi, X., Wong, Y. K., Wu, J., Xie, F., Hu, D., Wang, Q., Wang, J., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00375-9 · Cited by 71
“The CSF EVs of patients with AD contain high levels of Aβ, which can cause damage to neurons in vitro and in animal models in vivo [59, 96].”
BackgroundThe Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases
Ghosh, M., & Pearse, D. D. (2024) · Cells · doi:10.3390/cells13221834 · Cited by 77
Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
Lombardi, M., Gabrielli, M., Adinolfi, E., & Verderio, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654023 · Cited by 66
Research progress in Alzheimer's disease and bone-brain axis
Zhang, F., & Zhang, W. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102341 · Cited by 67
Chiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 72
Metadata
- Authors
- Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Uppsala University (SE)
- Corresponding author
- Hallbeck, Martin
- Venue
- Acta Neuropathologica
- Published
- 2018-06-13
- Volume
- 136
- Issue
- 1
- Pages
- 41-56
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6015111
- OpenAlex
- W2807776100
- Cited by
- 527
- References
- 60
- Citations by year
- 2026: 48 · 2025: 70 · 2024: 71 · 2023: 64 · 2022: 60 · 2021: 74 · 2020: 82 · 2019: 50 · 2018: 6
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Vetenskapsrådet (523-2013-2735)
- Alzheimerfonden
- Hjärnfonden
- Hans-Gabriel och Alice Trolle Wachtmeister Stiftelse för Medicinsk forskning
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Knut och Alice Wallenbergs Stiftelse
- Demensförbundet
- Linköpings Universitet
- Region Östergötland
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, exosomes, amyloid-beta oligomers, prion-like propagation, extracellular vesicles, tau pathology, exosome secretion, exosome uptake, neurotoxicity
- MeSH terms
- Tsg101 Protein, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cell Line, Transformed, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, L-Lactate Dehydrogenase, Male, Membrane Proteins, Middle Aged, Neuroblastoma, Organic Chemicals, Peptide Fragments, Transcription Factors, Amyloid beta-Peptides, Culture Media, Conditioned, Coculture Techniques, Protein Transport, Pluripotent Stem Cells, Microscopy, Electron, Transmission, Exosomes, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.